Home »

Articles, tagged with "eli lilly", page 2

Bookmark and Share

New Pancreatic Cancer Treatment Found to Decrease Size of Tumor

10th February 2009
Copyright (c) 2009 Katie Kelley Recent news reports have provided much acclaim to a "groundbreaking medical trial" from the University of Colorado Hospital, which has allegedly discovered a method of treatment that would "shrink the tumor with very con... Read >
Author: LegalView

Cancer Patients Find Success in Fighting Pancreatic Conditions By Administering Multiple Therapies

17th January 2009
A Science Daily news article recently reported on the research being conducted by University of Pittsburg Cancer Institute (UPCI) researchers that pancreatic cancer patients find more success prior to surgery by receiving a combination of therapies includ... Read >
Author: Legal

Those With Diabetes and Cancer Could Receive a Fatal Diagnosis

16th January 2009
Copyright (c) 2009 Katie Kelley Researchers have found that a cancer patient that previously suffered from a diabetes diagnosis may be at an increased risk of a fatal outcome than patients not suffering from diabetes. 

The study included resear... Read >
Author: LegalView

News from the stock exchange — things are looking up

01st December 2008
There are always bright moments in your day. No matter how many other items of news cross your desk which show economies slowing down or people doing bad things, there is always something that can lift your spirits again. In this instance, we have the thi... Read >
Author: John Scott

Drug Linked to Pancreatitis Among Diabetics

29th September 2008
Copyright (c) 2008 Katie Kelley In 2005, Eli Lilly and Amylin Pharmaceuticals, together released a type 2 diabetes drug known as Byetta (exenatide). The drug acts as a glucose controller for non-insulin dependent diabetics. Under investigation, the ... Read >
Author: LegalView

Intermediate- Acting Insulin

13th August 2008
The intermediate-acting insulins are NPH, Purified Pork N, Hetin 2 NPH, Novolin N, Humulin NPH, Hetin 2 Lente, Novolin L (human), and Humulin L. These start working in 1 to 2 hours, with peak action in 4 to 12 hours. The pharmacokinetic duration of actlon... Read >
Author: Alien

Diabetes management equipment: Lancing devices and insulin delivery devices

06th February 2008
The painful art of finger pricking (necessary to get the drop of blood used for testing how much sugar is in your bloodstream at any one time) has improved vastly with a new device from Roche called the Multiclix which changes lancets for you without the ... Read >
Author: Desang kitbags

Treating ADHD and Reading Disorders

30th October 2007
About 30% of children with ADHD also have some form of reading disorder, such as dyslexia. Recently, a study was done to examine whether or not ADHD treatment helped these children with their reading problems. The study was funded by the pharmaceutical co... Read >
Author: Anthony Kane, MD

Indiana- Industrial State on the Great Lakes

10th June 2007
Indiana is still a major center of heavy manufacturing industry, although not as intensely as it used to be. Northwest Indiana is the largest steel producing area in the U.S. and it is a sort of unique area in that it has maintained its industrial pr... Read >
Author:

Permax Recall

30th April 2007
Following two recent studies, the Federal Drug Administration (FDA) announced a Permax recall on March 29, 2007. The Permax recall includes both the name brand Permax (peroglide) and the generic versions of peroglide. Current studies have revealed Permax ... Read >
Author: Steve Fields

How To Get Lawsuit Funding on Zyprexa Class Action Lawsuit

18th April 2007
No - Risk Lawsuit Funds for Zyprexa, Product Liability Lawsuit Plaintiffs Plaintiffs involved in pharmaceuticals class action lawsuit and product liability lawsuit like Zyprexa, Vioxx, Fen-Phen etc, can now get Lawsuit cash advances. 99% of plaintiffs ... Read >
Author: Paul Sherman

Off Label Drug Use Marketing

10th January 2007
When a drug is approved by the FDA for a specific use, pharmaceutical companies are only allowed to market the drug for that use. Any drug may be prescribed by a doctor for any use, including uses not described in the approved labeling. This is consider... Read >
Author: Greg Edwards

PPD Names Thomas Rosanske Executive Director of Product Development Analytical Services

07th December 2006
WILMINGTON, N.C. (April 25, 2006) - PPD, Inc. (Nasdaq: PPDI) today announced Thomas Rosanske, Ph.D., has joined the company as executive director of product development analytical services for its cGMP laboratory. Rosanske's responsibilities include st... Read >
Author: Julie McKenzie
Bookmark and Share
1 2